Outpacing
cancer starts with early detection

Detecting cancer early can make a world of difference. Freenome is setting a new pace for early cancer detection by combining the latest in science and artificial intelligence, with the ease of a standard blood draw.

Outpacing
cancer starts with early detection

Detecting cancer early can make a world of difference. Freenome is setting a new pace for early cancer detection by combining the latest in science and artificial intelligence, with the ease of a standard blood draw.

Outpacing cancer starts with early detection
Two Freenome clinicians working in a lab where outpacing cancer starts with early detection

A novel approach to screening

Freenome’s intelligent screening platform uses multiomics technology to detect cancer in its earliest, most treatable stages.

Powered by a rigorous clinical program

Our research programs drive discovery, development, and validation of our early cancer detection tests.

A doctor having a discussion with a patient

Multi-disciplinary leadership with purpose

We bring together passionate creators and ambitious builders. Together, we are relentless in pushing for what’s possible in early cancer detection.

woman in Freenome office lab

Join our team

Are you ready to make a significant impact? Explore our job openings and see how your skills can help us redefine the future of cancer screening.